United Kingdom· GB-APID-43167511000001107
Fabhalta 200mg capsules
A iptacopan product containing iptacopan, registered in United Kingdom by Novartis Pharmaceuticals UK Ltd. The same ATC class is registered in 14 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Iptacopan is registered in 14 of 19 countries.
Countries holding a registration under ATC L04AJ08 (iptacopan), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 8 of them publish a price we can compare per daily dose
Iptacopan · ATC L04AJ08
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of iptacopan costs, country by country.
Normalised to the WHO defined daily dose (0.4 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Iptacopan · price per daily dose (0.4 g)
USD · FX 28 Sept 2026
- CH Switzerland$1117.78
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Iptacopan
- Manufacturer
- Novartis Pharmaceuticals UK Ltd
- Country
- United Kingdom (GB)
- ATC code
- L04AJ08
- ATC class
- Iptacopan
- Defined daily dose
- 0.4 g, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin7613421170776
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Iptacopan in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaFABHALTANovartis Europharm Limited, Dublin
- United StatesFABHALTANovartis Pharmaceuticals Corporation
- SwitzerlandFabhalta
- SpainFABHALTA 200 MG CAPSULAS DURASNovartis Europharm Limited
- FinlandFABHALTANovartis Europharm Limited
- FranceFABHALTA 200 mg, géluleNOVARTIS EUROPHARM (IRLANDE)
- BelgiumFabhalta 200 mgNovartis Europharm
- IcelandFabhaltaNovartis Europharm Limited*
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Fabhalta
- Liechtenstein · Fabhalta
- Norway · Fabhalta
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/0e902957-5ab5-46aa-b9f3-4433685793c3 GET /v1/drugs/0e902957-5ab5-46aa-b9f3-4433685793c3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "43167511000001107",
"desc": "Fabhalta 200mg capsules (Novartis Pharmaceuticals UK Ltd)",
"form": "Oral capsule",
"vpid": "43533711000001106",
"source": "dmd",
"vtm_id": "43505811000001108",
"strength": "200 mg",
"substance": "Iptacopan",
"ingredient": "Iptacopan hydrochloride monohydrate",
"supplier_code": "2920101000001102"
}See everything about iptacopan.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.